UroGen Pharma Ltd. (URGN) Stock News & Chart | StockAdder

(URGN)

UroGen Pharma Ltd.

Stock chart and latest news for UroGen Pharma Ltd., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

UroGen Pharma Ltd. News

PRO

URGN SEC Filings - Urogen Pharma 10-K, 10-Q, 8-K Forms

Apr 12, 2026 Sahm

UroGen Pharma (URGN) Is Up 14.6% After Phase 3 ENVISION Data And LG-UTUC Outreach Push

Apr 12, 2026 Yahoo Finance

Loss-Making UroGen Pharma Ltd. (NASDAQ:URGN) Expected To Breakeven In The Medium-Term

Dec 31, 2025 simplywall.st

UroGen Pharma Ltd. (NASDAQ:URGN) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Dec 5, 2025 Seeking Alpha

UroGen Pharma: Strong Potential As Zusduri Commercialization Accelerates

Nov 25, 2025 Investing.com

UroGen Pharma stock jumps after positive Phase 3 trial results

Nov 6, 2025 Quiver Quantitative

UroGen Pharma Ltd. to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

Feb 23, 2026 GuruFocus

UroGen Pharma (URGN) Analyst Ratings Remain Steady with Buy Rati

Jan 5, 2026 Yahoo Finance

Analysts Have Made A Financial Statement On UroGen Pharma Ltd.'s (NASDAQ:URGN) Third-Quarter Report

Nov 9, 2025 Stock Titan

Rare urinary cancer hits 6,000-7,000 yearly as UroGen starts clinician honors

Apr 8, 2026 simplywall.st

Market Sentiment Around Loss-Making UroGen Pharma Ltd. (NASDAQ:URGN)

Feb 9, 2026 Seeking Alpha

UroGen Pharma: Targeting Profits In 2027 (NASDAQ:URGN)